share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne

CRISPR Therapeutics | 4:持股變動聲明-高管 Bruno Julianne
美股sec公告 ·  06/24 17:36
Moomoo AI 已提取核心訊息
CRISPR Therapeutics COO Julianne Bruno sold 3,366 shares of the company's common stock on 06/21/2024, as per the latest SEC filings. The shares were sold at a price of $56.09 each, totaling approximately $188,798.94. This transaction followed an acquisition of 7,000 shares on 06/20/2024 through the exercise of derivative securities. After these transactions, Bruno directly holds 6,745 shares of CRISPR Therapeutics. Additionally, Bruno has an indirect beneficial ownership of 7,088 shares through The Julianne Bruno 2022 GRAT. The transactions have been reported as completed.
CRISPR Therapeutics COO Julianne Bruno sold 3,366 shares of the company's common stock on 06/21/2024, as per the latest SEC filings. The shares were sold at a price of $56.09 each, totaling approximately $188,798.94. This transaction followed an acquisition of 7,000 shares on 06/20/2024 through the exercise of derivative securities. After these transactions, Bruno directly holds 6,745 shares of CRISPR Therapeutics. Additionally, Bruno has an indirect beneficial ownership of 7,088 shares through The Julianne Bruno 2022 GRAT. The transactions have been reported as completed.
CRISPR Therapeutics首席運營官Julianne Bruno於06/21/2024根據最新的SEC文件出售了公司普通股的3,366股。每股售價爲56.09美元,總價值約爲188,798.94美元。此次交易是在通過衍生證券行使權利收購了7,000股股份後進行的。在這些交易之後,Bruno直接持有CRISPR Therapeutics的6,745股股份。此外,Bruno通過The Julianne Bruno 2022 GRAT擁有7,088股間接受益所有權。這些交易已被報告爲已完成。
CRISPR Therapeutics首席運營官Julianne Bruno於06/21/2024根據最新的SEC文件出售了公司普通股的3,366股。每股售價爲56.09美元,總價值約爲188,798.94美元。此次交易是在通過衍生證券行使權利收購了7,000股股份後進行的。在這些交易之後,Bruno直接持有CRISPR Therapeutics的6,745股股份。此外,Bruno通過The Julianne Bruno 2022 GRAT擁有7,088股間接受益所有權。這些交易已被報告爲已完成。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息